
Asian expert consensus updates mantle cell lymphoma treatment guidelines, highlighting uneven BTK inhibitor, ibrutinib and CAR T-cell access across Asia.
Express Scripts
Medco Health Solutions
Regulators have given their blessing for to buy , the final hurdle in a $29 billion deal creating the nation’s largest pharmacy benefits provider.
The Federal Trade Commission voted 3 to 1 to approve the acquisition on Monday, ending an eight-month inquiry into whether the deal would stifle competition in the pharmacy benefits industry. The agency’s approval is the closing of one of the largest deals of 2011, and one that was the subject of a lot of antitrust concerns.
Read the full story:
Source: The New York Times






